Other meaningful insights include: Patient characteristics associated with early uptake Height and weight, enabling calculation of exact BMI, which is critically relevant for this market Clinician-documented attributes relevant to treatment selection, such as other vitals, lifestyle factors, social determinants of health, and other GLP-1 decision drivers HCP prescribing behavior, including identification of early adopters Source of business Differentiation between new-to-therapy patients and switchers Rich insights like thesecaptured early are necessary to understand who is being treated, why specific therapies are chosen, and whether early adoption reflects substitution within the category or expansion of the treated population
Your muscles respond better to evenly distributed protein than getting all your protein in one huge meal
Theyre affordable, doctor-trusted, and formulated in the USA. The narration continues: You deserve to feel great in your body. The slickly produced ad suggests that rather than profiting from the weight-loss industry, Hims & Hers was taking a stand against it
These medications work directly on regions of the brain involved in appetite control, such as the hypothalamus, helping you feel fuller longer, reducing hunger sensations, and curbing cravings
That is very different from eating as little as possible
The most common medications classified as GLP-1 RAs are: Semaglutide (Ozempic, Wegovy) Terzepatide (Mounjaro, Zepbound), which also includes another hormone peptide called GIP along with GLP-1 I am not here to take shots at the medications themselves
